Advanced search
Publication Cover
Expert Review of Molecular Diagnostics Volume 5, 2005 - Issue 5
Submit an article Journal homepage
363
Views
88
CrossRef citations to date
0
Altmetric
Review

CSF biomarkers for Alzheimer’s disease: use in early diagnosis and evaluation of drug treatment

Kaj Blennow The Sahlgrenska Academy at Göteborg University, Department of Clinical Neuroscience, Section of Experimental Neuroscience, Sahlgrenska University Hospital, SE-431 80 Mölndal, Sweden. [email protected]
Pages 661-672 | Published online: 09 Jan 2014

Citations (88)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Hayrettin Tumani, Charlotte Teunissen, Sigurd Süssmuth, Markus Otto, Albert C Ludolph & Johannes Brettschneider. (2008) Cerebrospinal fluid biomarkers of neurodegeneration in chronic neurological diseases. Expert Review of Molecular Diagnostics 8:4, pages 479-494.
Read now
Erik Portelius, Henrik Zetterberg, Johan Gobom, Ulf Andreasson & Kaj Blennow. (2008) Targeted proteomics in Alzheimer’s disease: focus on amyloid-β. Expert Review of Proteomics 5:2, pages 225-237.
Read now
Hanno M Roder & Michael L Hutton. (2007) Microtubule-associated protein tau as a therapeutic target in neurodegenerative disease. Expert Opinion on Therapeutic Targets 11:4, pages 435-442.
Read now
Robert Bowser, Merit Cudkowicz & Rima Kaddurah-Daouk. (2006) Biomarkers for amyotrophic lateral sclerosis. Expert Review of Molecular Diagnostics 6:3, pages 387-398.
Read now
Oliver Schmidt, Thomas Schulenborg, Helmut E Meyer, Katrin Marcus & Michael Hamacher. (2005) How proteomics reveals potential biomarkers in brain diseases. Expert Review of Proteomics 2:6, pages 901-913.
Read now

Articles from other publishers (83)

Christine Zürcher & Christian Humpel. (2023) Saliva: a challenging human fluid to diagnose brain disorders with a focus on Alzheimer’s disease. Neural Regeneration Research 18:12, pages 2606-2610.
Crossref
Binita Rajbanshi, Anuj Guruacharya, James W. Mandell & George S. Bloom. (2023) Localization, induction, and cellular effects of tau phosphorylated at threonine 217 1 . Alzheimer's & Dementia 19:7, pages 2874-2887.
Crossref
Josef Marksteiner, Michaela Defrancesco & Christian Humpel. (2022) Saliva tau and phospho-tau-181 measured by Lumipulse in patients with Alzheimer’s disease. Frontiers in Aging Neuroscience 14.
Crossref
Leming Sun, Yang Lei, Yuerong Wang & Dingchang Liu. (2022) Blood-based Alzheimer's disease diagnosis using fluorescent peptide nanoparticle arrays. Chinese Chemical Letters 33:4, pages 1946-1950.
Crossref
Dhwani S. Korde & Christian Humpel. (2022) Western Agarose Native GeELution (WANGEL) with beta-amyloid and tau: Novel method to elute proteins or peptides using native agarose gels followed by Lumipulse assay. MethodsX 9, pages 101779.
Crossref
Michelle M. Nuño & Daniel L. Gillen. (2021) Censoring‐robust time‐dependent receiver operating characteristic curve estimators. Statistics in Medicine 40:30, pages 6885-6899.
Crossref
Lei Feng, Jinming Li & Rui Zhang. (2021) Current research status of blood biomarkers in Alzheimer’s disease: Diagnosis and prognosis. Ageing Research Reviews 72, pages 101492.
Crossref
Vincent Marcucci & Jeremy Kleiman. (2021) Biomarkers and Their Implications in Alzheimer’s Disease: A Literature Review. Exploratory Research and Hypothesis in Medicine 000:000, pages 000-000.
Crossref
Imrich Blasko, Michaela Defrancesco, Herbert Oberacher, Lorin Loacker, Georg Kemmler, Josef Marksteiner & Christian Humpel. (2021) Plasma phosphatidylcholines and vitamin B12/folate levels are possible prognostic biomarkers for progression of Alzheimer's disease. Experimental Gerontology 147, pages 111264.
Crossref
Yiyun Jin, Devkee Mahesh Vadukul, Dimitra Gialama, Ying Ge, Rebecca Thrush, Joe Thomas White & Francesco Antonio Aprile. (2021) The Diagnostic Potential of Amyloidogenic Proteins. International Journal of Molecular Sciences 22:8, pages 4128.
Crossref
Ram Sagar, Pujita Pathak, Balint Pandur, Sujung Jun Kim, Jiaxin Li & Vasiliki Mahairaki. 2021. GeNeDis 2020. GeNeDis 2020 403 408 .
Jozef HanesAndrej KovacHlin KvartsbergEva KontsekovaLubica FialovaStanislav Katina, Branislav KovacechEva StevensJakub HortMartin VyhnalekLynn BoonkampMichal NovakHenrik ZetterbergOskar HanssonPhilip Scheltens, Kaj BlennowCharlotte E. TeunissenNorbert Zilka. (2020) Evaluation of a novel immunoassay to detect p-tau Thr217 in the CSF to distinguish Alzheimer disease from other dementias. Neurology 95:22.
Crossref
Md. Sahab Uddin, Md. Tanvir Kabir, Md. Sohanur Rahman, Tapan Behl, Philippe Jeandet, Ghulam Md Ashraf, Agnieszka Najda, May N. Bin-Jumah, Hesham R. El-Seedi & Mohamed M. Abdel-Daim. (2020) Revisiting the Amyloid Cascade Hypothesis: From Anti-Aβ Therapeutics to Auspicious New Ways for Alzheimer’s Disease. International Journal of Molecular Sciences 21:16, pages 5858.
Crossref
Shahul Hameed, Jong-Ling Fuh, Vorapun Senanarong, Esther Gunaseli M. Ebenezer, Irene Looi, Jacqueline C. Dominguez, Kyung Won Park, Ananda Krishna Karanam & Oliver Simon. (2020) Role of Fluid Biomarkers and PET Imaging in Early Diagnosis and its Clinical Implication in the Management of Alzheimer’s Disease. Journal of Alzheimer's Disease Reports 4:1, pages 21-37.
Crossref
Wei-Chieh Weng, Wen-Yi Huang, Hsiang-Yu Tang, Mei-Ling Cheng & Kuan-Hsing Chen. (2019) The Differences of Serum Metabolites Between Patients With Early-Stage Alzheimer's Disease and Mild Cognitive Impairment. Frontiers in Neurology 10.
Crossref
M.A. Arya, Maneesha K. Manoj Kumar, M. Sabitha, Krishnakumar N. Menon & Sreeja C. Nair. (2019) Nanotechnology approaches for enhanced CNS delivery in treating Alzheimer's disease. Journal of Drug Delivery Science and Technology 51, pages 297-309.
Crossref
Josef Marksteiner, Herbert Oberacher & Christian Humpel. (2019) Acyl-Alkyl-Phosphatidlycholines are Decreased in Saliva of Patients with Alzheimer’s Disease as Identified by Targeted Metabolomics. Journal of Alzheimer's Disease 68:2, pages 583-589.
Crossref
Maria Dantas Costa Lima Godoy, Marco Aurélio Fornazieri, Richard L. Doty, Fábio de Rezende Pinna, José Marcelo Farfel, Glaucia Bento dos Santos, Mariana Molina, Renata E. L. Ferretti-Rebustini, Renata E. P. Leite, Claudia K. Suemoto, Lea T. Grinberg, Carlos A. G. Pasqualucci, Richard Louis Voegels, Ricardo Nitrini & Wilson Jacob Filho. (2018) Is Olfactory Epithelium Biopsy Useful for Confirming Alzheimer’s Disease?. Annals of Otology, Rhinology & Laryngology 128:3, pages 184-192.
Crossref
Keping Chen, Tianli Gao, Zhimao Bai & Zuanning Yuan. (2018) Circulating APP, NCAM and Aβ serve as biomarkers for Alzheimer’s disease. Brain Research 1699, pages 117-120.
Crossref
Dimitrios Zafeiris, Sergio Rutella & Graham Roy Ball. (2018) An Artificial Neural Network Integrated Pipeline for Biomarker Discovery Using Alzheimer's Disease as a Case Study. Computational and Structural Biotechnology Journal 16, pages 77-87.
Crossref
Josef Marksteiner, Imrich Blasko, Georg Kemmler, Therese Koal & Christian Humpel. (2017) Bile acid quantification of 20 plasma metabolites identifies lithocholic acid as a putative biomarker in Alzheimer’s disease. Metabolomics 14:1.
Crossref
Tao Yue, Xinghua Jia, Jennifer PetrosinoLeming SunZhen FanJesse FineRebecca Davis, Scott Galster, Jeff Kuret, Douglas W. Scharre & Mingjun Zhang. (2017) Computational integration of nanoscale physical biomarkers and cognitive assessments for Alzheimer’s disease diagnosis and prognosis. Science Advances 3:7.
Crossref
Herbert Oberacher, Kathrin Arnhard, Caroline Linhart, Angela Diwo, Josef Marksteiner & Christian Humpel. (2017) Targeted Metabolomic Analysis of Soluble Lysates from Platelets of Patients with Mild Cognitive Impairment and Alzheimer’s Disease Compared to Healthy Controls: Is PC aeC40:4 a Promising Diagnostic Tool?. Journal of Alzheimer's Disease 57:2, pages 493-504.
Crossref
Rongqiao HeJing Lu & Rongqiao He. 2017. Formaldehyde and Cognition. Formaldehyde and Cognition 167 189 .
Luke W. Bonham, Rahul S. Desikan & Jennifer S. Yokoyama. (2016) The relationship between complement factor C3, APOE ε4, amyloid and tau in Alzheimer’s disease. Acta Neuropathologica Communications 4:1.
Crossref
. 2016. Advances in Chromatography. Advances in Chromatography 75 102 .
Reza M. Mohamadi, Zuzana Svobodova, Zuzana Bilkova, Markus Otto, Myriam Taverna, Stephanie Descroix & Jean-Louis Viovy. (2015) An integrated microfluidic chip for immunocapture, preconcentration and separation of β-amyloid peptides. Biomicrofluidics 9:5.
Crossref
Yongyao Fu, Deming Zhao, Bo Pan, Jihong Wang, Yongyong Cui, Fushan Shi, Chunyu Wang, Xiaoming Yin, Xiangmei Zhou & Lifeng Yang. (2015) Proteomic Analysis of Protein Expression Throughout Disease Progression in a Mouse Model of Alzheimer’s Disease. Journal of Alzheimer's Disease 47:4, pages 915-926.
Crossref
Sabiha Khatoon, Sonia Chalbot, Silvia Bolognin, Jukka Puoliväli & Khalid Iqbal. (2015) Elevated Tau Level in Aged Rat Cerebrospinal Fluid Reduced by Treatment with a Neurotrophic Compound. Journal of Alzheimer's Disease 47:3, pages 557-564.
Crossref
Barbara Plagg, Josef Marksteiner, Kathrin M. Kniewallner & Christian Humpel. (2015) Platelet dysfunction in hypercholesterolemia mice, two Alzheimer’s disease mouse models and in human patients with Alzheimer’s disease. Biogerontology 16:4, pages 543-558.
Crossref
Jonathan Gooblar, Brian D. Carpenter, Mary A. Coats, John C. Morris & B. Joy Snider. (2014) The influence of cerebrospinal fluid (CSF) biomarkers on clinical dementia evaluations. Alzheimer's & Dementia 11:5, pages 533.
Crossref
Simone Lista, B. Dubois & H. Hampel. (2014) Paths to Alzheimer’s disease prevention: From modifiable risk factors to biomarker enrichment strategies. The journal of nutrition, health & aging 19:2, pages 154-163.
Crossref
Fucui Ma & Daicheng Liu. (2015) 17β-trenbolone, an anabolic–androgenic steroid as well as an environmental hormone, contributes to neurodegeneration. Toxicology and Applied Pharmacology 282:1, pages 68-76.
Crossref
Antonio Conti & Massimo Alessio. 2015. Omic Studies of Neurodegenerative Disease: Part A. Omic Studies of Neurodegenerative Disease: Part A 117 152 .
Sun-Ho Han, Jong-Chan Park & Inhee Mook-Jung. 2015. Aging Mechanisms. Aging Mechanisms 341 354 .
O. Lardinois, P. J. Kirby, D. L. Morgan, R. C. Sills, K. B. Tomer & L. J. Deterding. (2014) Mass spectrometric analysis of rat cerebrospinal fluid proteins following exposure to the neurotoxicant carbonyl sulfide. Rapid Communications in Mass Spectrometry 28:23, pages 2531-2538.
Crossref
Yongyao Fu, Deming Zhao & Lifeng Yang. (2014) Protein-Based Biomarkers in Cerebrospinal Fluid and Blood for Alzheimer’s Disease. Journal of Molecular Neuroscience 54:4, pages 739-747.
Crossref
Richard Rubenstein. 2014. Biomarkers of Brain Injury and Neurological Disorders. Biomarkers of Brain Injury and Neurological Disorders 415 441 .
Arunabha Chakrabarti, Atri Chatterjee, Mohor B. Sengupta, Partha Chattopadhyay & Debashis Mukhopadhyay. (2014) Altered Levels of Amyloid Precursor Protein Intracellular Domain-interacting Proteins in Alzheimer Disease. Alzheimer Disease & Associated Disorders 28:3, pages 283-290.
Crossref
Xiaojing Sui, Jianjun Liu & Xifei Yang. (2014) Cerebrospinal fluid biomarkers of Alzheimer’s disease. Neuroscience Bulletin 30:2, pages 233-242.
Crossref
Josef Marksteiner, Douglas Imarhiagbe, Michaela Defrancesco, Eberhard A. Deisenhammer, Georg Kemmler & Christian Humpel. (2014) Analysis of 27 vascular-related proteins reveals that NT-proBNP is a potential biomarker for Alzheimer's disease and mild cognitive impairment: A pilot-study. Experimental Gerontology 50, pages 114-121.
Crossref
Kaj Blennow, Harald Hampel & Henrik Zetterberg. (2013) Biomarkers in Amyloid-β Immunotherapy Trials in Alzheimer’s Disease. Neuropsychopharmacology 39:1, pages 189-201.
Crossref
Jing Lu, Junye Miao, Tao Su, Ying Liu & Rongqiao He. (2013) Formaldehyde induces hyperphosphorylation and polymerization of Tau protein both in vitro and in vivo. Biochimica et Biophysica Acta (BBA) - General Subjects 1830:8, pages 4102-4116.
Crossref
M Di Carlo, D Giacomazza & P L San Biagio. (2012) Alzheimer’s disease: biological aspects, therapeutic perspectives and diagnostic tools. Journal of Physics: Condensed Matter 24:24, pages 244102.
Crossref
Marie M. Svedberg, Obaidur Rahman & Håkan Hall. (2012) Preclinical studies of potential amyloid binding PET/SPECT ligands in Alzheimer's disease. Nuclear Medicine and Biology 39:4, pages 484-501.
Crossref
Mohammed Aiyaz, Michelle K. Lupton, Petroula Proitsi, John F. Powell & Simon Lovestone. (2012) Complement activation as a biomarker for Alzheimer's disease. Immunobiology 217:2, pages 204-215.
Crossref
Eddie Takahashi, Anita Howe, Ole Vesterqvist & Zhaosheng Lin. 2012. SELDI-TOF Mass Spectrometry. SELDI-TOF Mass Spectrometry 227 236 .
Eric C. Yuen, Enchi Liu & Gene G. Kinney. 2012. Development of Antibody-Based Therapeutics. Development of Antibody-Based Therapeutics 341 354 .
Harald Hampel, Gordon Wilcock, Sandrine Andrieu, Paul Aisen, Kaj Blennow, K. Broich, Maria Carrillo, Nick C. Fox, Giovanni B. Frisoni, Maria Isaac, Simon Lovestone, Agneta Nordberg, David Prvulovic, Christina Sampaio, Philip Scheltens, Michael Weiner, Bengt Winblad, Nicola Coley & Bruno Vellas. (2011) Biomarkers for Alzheimer's disease therapeutic trials. Progress in Neurobiology 95:4, pages 579-593.
Crossref
Gábor Juhász, István Földi & Botond Penke. (2011) Systems biology of Alzheimer's disease: How diverse molecular changes result in memory impairment in AD. Neurochemistry International 58:7, pages 739-750.
Crossref
Christian Humpel. (2011) Identifying and validating biomarkers for Alzheimer's disease. Trends in Biotechnology 29:1, pages 26-32.
Crossref
Felix Bermejo-Pareja, Desiree Antequera, Teo Vargas, Jose A Molina & Eva Carro. (2010) Saliva levels of Abeta1-42 as potential biomarker of Alzheimer's disease: a pilot study. BMC Neurology 10:1.
Crossref
Audrey Gabelle, Stéphane Roche, Christian Gény, Karim Bennys, Pierre Labauge, Yannick Tholance, Isabelle Quadrio, Laurent Tiers, Baptiste Gor, Chloé Chaulet, Alain Vighetto, Bernard Croisile, Pierre Krolak-Salmon, Jacques Touchon, Armand Perret-Liaudet & Sylvain Lehmann. (2010) Correlations between soluble α/β forms of amyloid precursor protein and Aβ38, 40, and 42 in human cerebrospinal fluid. Brain Research 1357, pages 175-183.
Crossref
Chenggang Zhang. (2010) Proteomic Studies on the Development of the Central Nervous System and Beyond. Neurochemical Research 35:10, pages 1487-1500.
Crossref
Mohamad Reza Mohamadi, Zuzana Svobodova, Romain Verpillot, Hermann Esselmann, Jens Wiltfang, Markus Otto, Myriam Taverna, Zuzana Bilkova & Jean-Louis Viovy. (2010) Microchip Electrophoresis Profiling of Aβ Peptides in the Cerebrospinal Fluid of Patients with Alzheimer’s Disease. Analytical Chemistry 82:18, pages 7611-7617.
Crossref
Norbert Zilka, Miroslava Korenova, Branislav Kovacech, Khalid Iqbal & Michal Novak. (2010) CSF phospho-tau correlates with behavioural decline and brain insoluble phospho-tau levels in a rat model of tauopathy. Acta Neuropathologica 119:6, pages 679-687.
Crossref
Diego Bohoyo, Isabelle Le Potier, Céline Rivière, Hans Klafki, Jens Wiltfang & Myriam Taverna. (2010) A quantitative CE method to analyse tau protein isoforms using coated fused silica capillaries. Journal of Separation Science 33:8, pages 1090-1098.
Crossref
Kaj Blennow, Harald Hampel, Michael Weiner & Henrik Zetterberg. (2010) Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nature Reviews Neurology 6:3, pages 131-144.
Crossref
Christianto B. Lumenta, Joaquín Zamarro Parra, Mariano Espinosa de Rueda Ruiz, Guillermo Parrilla Reverter, Antonio Moreno Diéguez, Anders Fuglsang-Frederiksen, Peter Orm Hansen, Jan Jakob A. Mooij, H. L. Journée, Jan Abrahamsen & Flemming Gjerris. 2010. Neurosurgery. Neurosurgery 27 59 .
Reinhilde Mlekusch & Christian Humpel. (2009) Matrix metalloproteinases-2 and -3 are reduced in cerebrospinal fluid with low beta-amyloid1–42 levels. Neuroscience Letters 466:3, pages 135-138.
Crossref
Christoph Zenzmaier, Josef Marksteiner, Andreas Kiefer, Peter Berger & Christian Humpel. (2009) Dkk-3 is elevated in CSF and plasma of Alzheimer’s disease patients. Journal of Neurochemistry 110:2, pages 653-661.
Crossref
Maria Zellner, Michael Veitinger & Ellen Umlauf. (2009) The role of proteomics in dementia and Alzheimer’s disease. Acta Neuropathologica 118:1, pages 181-195.
Crossref
N. Guerreiro, B. Gomez-Mancilla, B. Williamson, M. Minkoff & S. Guertin. (2009) Proteomic Profiling of Cerebrospinal Fluid by 8-Plex iTRAQ Reveals Potential Biomarker Candidates of Alzheimer’s Disease. Clinical Proteomics 5:2, pages 114-124.
Crossref
Henrik Zetterberg, Ulf Andreasson & Kaj Blennow. (2009) CSF Antithrombin III and Disruption of the Blood-Brain Barrier. Journal of Clinical Oncology 27:13, pages 2302-2303.
Crossref
K. Blennow & H. Zetterberg. (2009) Use of CSF biomarkers in Alzheimer’s disease clinical trials. The Journal of Nutrition, Health and Aging 13:4, pages 358-361.
Crossref
Hye Jin Hwang, Thomas Quinn & Jing Zhang. 2009. Neuroproteomics. Neuroproteomics 263 276 .
Christian Humpel & Josef Marksteiner. 2009. The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes. The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes 3 12 .
Lisbell D. Estrada & Claudio Soto. 2009. Current Hypotheses and Research Milestones in Alzheimer's Disease. Current Hypotheses and Research Milestones in Alzheimer's Disease 217 226 .
Jing Zhang, C. Dirk Keene, Catherine Pan, Kathleen S. Montine & Thomas J. Montine. (2008) Proteomics of Human Neurodegenerative Diseases. Journal of Neuropathology & Experimental Neurology 67:10, pages 923-932.
Crossref
Susanna Schraen-Maschke, Nicolas Sergeant, Claire-Marie Dhaenens, Stéphanie Bombois, Vincent Deramecourt, Marie-Laure Caillet-Boudin, Florence Pasquier, Claude-Alain Maurage, Bernard Sablonnière, Eugeen Vanmechelen & Luc Buée. (2008) Tau as a biomarker of neurodegenerative diseases. Biomarkers in Medicine 2:4, pages 363-384.
Crossref
Kurt A. Jellinger, Bernd Janetzky, Johannes Attems & Elisabeth Kienzl. (2008) Biomarkers for early diagnosis of Alzheimer disease: ‘ALZheimer ASsociated gene’- a new blood biomarker?. Journal of Cellular and Molecular Medicine 12:4, pages 1094-1117.
Crossref
Kaj BlennowHenrik Zetterberg. (2008) What is the future for CSF biomarkers in the prediction of cognitive decline and Alzheimer’s disease?. Aging Health 4:3, pages 213-215.
Crossref
C Lanni, M Racchi, G Mazzini, A Ranzenigo, R Polotti, E Sinforiani, L Olivari, M Barcikowska, M Styczynska, J Kuznicki, A Szybinska, S Govoni, M Memo & D Uberti. (2007) Conformationally altered p53: a novel Alzheimer's disease marker?. Molecular Psychiatry 13:6, pages 641-647.
Crossref
Paul Cutler, Emma L. Akuffo, Wanda M. Bodnar, Deborah M. Briggs, John B. Davis, Christine M. Debouck, Steven M. Fox, Rachel A. Gibson, Darren A. Gormley, Joanna D. Holbrook, A. Jacqueline Hunter, Emma E. Kinsey, Rabinder Prinjha, Jill C. Richardson, Allen D. Roses, Marjorie A. Smith, Nikos Tsokanas, David R. Willé, Wen Wu, John W. Yates & Israel S. Gloger. (2008) Proteomic identification and early validation of complement 1 inhibitor and pigment epithelium‐derived factor: Two novel biomarkers of Alzheimer's disease in human plasma. PROTEOMICS – Clinical Applications 2:4, pages 467-477.
Crossref
Martin H. Maurer. (2008) Proteomics of brain extracellular fluid (ECF) and cerebrospinal fluid (CSF). Mass Spectrometry Reviews, pages n/a-n/a.
Crossref
Bogdan O. Popescu. (2007) Still debating a cause and diagnostic criteria for Alzheimer's disease. Journal of Cellular and Molecular Medicine 11:6, pages 1225-1226.
Crossref
Jing Zhang. (2007) Proteomics of human cerebrospinal fluid – the good, the bad, and the ugly. PROTEOMICS – Clinical Applications 1:8, pages 805-819.
Crossref
Kathryn M. Bell & Steven E. Kornguth. 2007. Handbook of Biosensors and Biochips. Handbook of Biosensors and Biochips.
Zsuzsanna Nagy. (2007) The dysregulation of the cell cycle and the diagnosis of Alzheimer's disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1772:4, pages 402-408.
Crossref
Shen Hu, Joseph A. Loo & David T. Wong. (2006) Human body fluid proteome analysis. PROTEOMICS 6:23, pages 6326-6353.
Crossref
Sheng Pan, Yan Wang, Joseph F. Quinn, Elaine R. Peskind, Dana Waichunas, Jake T. Wimberger, Jinghua Jin, Jane G. Li, David Zhu, Catherine Pan & Jing Zhang. (2006) Identification of Glycoproteins in Human Cerebrospinal Fluid with a Complementary Proteomic Approach. Journal of Proteome Research 5:10, pages 2769-2779.
Crossref
Howard Schulman. (2006) Biomarkers to advance drug development for Alzheimer’s disease. Future Neurology 1:4, pages 409-415.
Crossref
. (2006) Current awareness in geriatric psychiatry. International Journal of Geriatric Psychiatry 21:4, pages 401-408.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.